PolyNovo announced the purchase of an adjoining office/warehouse facility. The intention is to combine the facilities and buildings allowing an expanded production facility suitable for several years. PolyNovo has significant near-term growth opportunities including increased US, Australia and New Zealand sales, the imminent NovoSorb BTM CE Mark opening the European and SE Asian markets, and entry into the Hernia and Breast markets and Asian registrations. The purchase of the adjoining property and renewal of the 10-year lease of the existing facility will allow medium term stability of supply of NovoSorb BTM to global markets. PolyNovo can now join and expand the production facility and install Hernia and Breast production equipment. NovoSorb polymer production will be completed in the one expanded facility reducing cost and leveraging the skills and experience of scientific and production teams. PolyNovo has funded the purchase from cash reserves.